As wellness-focused adults look beyond traditional NAD+ supplements in 2026, this Pallas Health review examines the clinician-guided daily nasal spray and weekly injection options, $79 and $89 first-month starting prices, ongoing plan costs, and the key details prospective patients are checking before deciding whether to enroll.
NEWARK, DE / ACCESS Newswire / August 12, 2026 / Quick heads-up before we dive in: this is a paid advertorial, and a commission may be earned if you purchase through the links here. Product claims are attributed to the brand and aren't independently endorsed. Pallas Health's NAD+ program is a compounded prescription medication - not a dietary supplement - that isn't FDA-approved and hasn't been evaluated by the FDA for safety, effectiveness, or quality. Official site: pallashealth.co. Reviewed August 2026 - confirm current details before ordering.
Pallas Health NAD+ Reviews: Healthy-Aging Buyers Taking NAD+ More Seriously Discover the Clinician-Reviewed Spray or Injection Program (Consumer Research)
TL;DR: Pallas Health's NAD+ Program at a Glance
Here's the short version: Pallas Health connects you with a US-licensed clinician who can prescribe NAD+ - your choice of a daily nasal spray or a weekly injection - for everyday energy or a healthy aging routine, no clinic visit required. Pricing starts at $79 (spray) or $89 (injection) for the first month, then averages $189-$199 monthly, and nothing ships until a clinician actually prescribes it.
You saw an ad for Pallas Health's NAD+ program. Maybe it was Instagram, maybe a wellness newsletter, maybe a friend's story about "boosting energy at the cellular level." Something caught your attention - and now you're doing exactly what smart buyers do before handing over a card number for a subscription that renews every 12 weeks: checking the details first.
Good instinct. Two things came up while checking that most coverage of this program won't tell you. First, Pallas's own governing Terms of Service describe the underlying compounded-medication service using language written for its GLP-1 line - not NAD+. Second, the brand names two medical leaders on its clinical disclosures page; independently cross-checking both against the federal provider registry and other public directories, both check out as real, actively practicing physicians. One additional claimed credential goes a step further than what's independently corroborated - covered in full below, with exactly what to ask Pallas before you enroll.
Review Pallas Health's NAD+ program information - but before you click through, here's what the brand's own pages, terms of service, and clinical disclosures actually say, laid out plainly.
What Is Pallas Health's NAD+ Program and Who Is It For?
Pallas Health is a telehealth technology platform operated by Brentmoor, Inc. The company is better known for its compounded GLP-1 weight-loss programs (semaglutide and tirzepatide). Pallas's platform-level clinical disclosures name Brentmoor, Inc., Lion MD, CareValidate, and a network of dispensing pharmacies as the entities behind every program on the platform. The live NAD+ pages run on that same Pallas platform, but as covered in detail later in this article, the published Terms of Service still describe the compounded-medication service using GLP-1-specific language - so how fully every platform-wide term applies to NAD+ specifically is worth confirming directly with Pallas rather than assuming. NAD+ is marketed under Pallas's "Anti-aging" category, positioned around two goals the brand names directly - everyday energy and healthy aging - rather than any specific diagnosed condition.
According to the brand's materials, the program is built for adults who want a prescribed, pharmacist-dispensed version of NAD+ rather than an over-the-counter supplement, and who are comfortable with a synchronous or asynchronous online intake process standing in for an in-person doctor's visit. It is explicitly not positioned as a treatment for a specific diagnosed medical condition - the brand's own FAQ states plainly that a clinician "determines whether NAD+ is appropriate for you - it isn't right for everyone."
Based on everything documented in this article, this program tends to make the most sense if:
You want a clinician actually reviewing your case before anything ships - not just a checkout button
You'd rather pay nothing upfront-at-risk than take a chance on an unreviewed purchase: if a clinician doesn't prescribe, Pallas states you're refunded in full, so there's no cost to finding out whether you qualify
You want to choose your own delivery method - a daily nasal spray if needles aren't your thing, or a weekly injection if you'd rather handle it once a week
You value knowing exactly who's involved in your care: this article could name the operating company, the medical group, and every partner pharmacy because Pallas actually discloses them - more detail than a typical telehealth landing page volunteers up front
None of that makes this the right choice for every reader - the brand's own words, "it isn't right for everyone," are worth taking at face value. But if the list above sounds like what you were hoping to find when you clicked that ad, the mechanics below are what to actually check before you commit.
See today's Pallas Health NAD+ pricing and what's included
The brand's materials indicate this is not a weight-loss product; Pallas sells a separate compounded and brand-name GLP-1 weight-management program, with its own pricing, entity structure, and pharmacy network, for that. Anyone arriving at the NAD+ page from a weight-loss-focused ad has landed on the wrong product page.
What Does the NAD+ Program Actually Include?
Per the official site, one plan price is described as covering four things bundled together, not just the medication itself:
Access to a US-licensed clinician who reviews your intake and decides whether to prescribe
Ongoing check-ins with your assigned clinician
Care-team messaging for questions between visits
The NAD+ medication itself, shipped from a compounding pharmacy, but only if and after a clinician prescribes it
Brand-attributed language on the product page states there's "no separate membership fee" layered on top of the medication cost - the quoted monthly figure is presented as the all-in price. That claim is addressed directly in the Pricing section below, alongside the visit-deposit mechanic that can apply in some states.
Pallas Health NAD+ Dose and Formulation: Nasal Spray or Injection
Per the brand's materials, patients choose their preferred delivery method during intake, and a clinician confirms it's appropriate and personalizes dosing from there. Two options are offered:
Daily nasal spray - no needles, self-administered once per day at home, according to the brand.
Weekly subcutaneous injection - self-administered once per week, per the product page.
The site does not publish a specific milligram dose, concentration, or per-unit volume for either form on the pages reviewed for this article - dosing is described as personalized by the prescribing clinician rather than fixed and disclosed up front. For this Pallas program specifically, that means the exact preparation is a clinical decision made after intake, not a fixed retail SKU you can check before applying. If a specific dose or concentration matters to your decision, that's a Verify-before-you-enroll item, covered later in this article.
The Three Entities Behind Your Prescription: Platform, Medical Group, and Pharmacy
Pallas Health's clinical disclosures page lays out a three-entity structure that's worth understanding before you enter payment information, because each entity plays a different legal role:
Entity 1 - the platform. Pallas Health, operated by Brentmoor, Inc., is the technology company running the website, intake questionnaire, and billing. Per the brand's own clinical disclosures, Pallas "does not employ medical providers, does not practice medicine, and does not direct clinical decisions." Pallas is not a prescriber and not a pharmacy.
Entity 2 - the licensed medical group. Clinical care is delivered by Lion MD, described on the clinical disclosures page as "a nationwide team of US-licensed medical professionals," operating through affiliated state-licensed professional corporations, in partnership with a clinical-operations platform called CareValidate that manages licensure verification and prescription workflow. Every prescribing clinician is stated to hold an active, unrestricted license in the state where the patient is physically located at the time of the encounter - this is the clinician-guided layer that actually makes the prescribing decision.
Entity 3 - the compounding pharmacy. Pallas does not own or operate a pharmacy. The clinical disclosures page lists six platform-wide partner pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, and Foothills Pharmacy. These are described as a mix of 503A compounding pharmacies (licensed and inspected by state boards of pharmacy) and 503B outsourcing facilities (registered with and inspected by the FDA under current Good Manufacturing Practice standards). One clarification worth making explicitly: FDA registration of a 503B facility is not the same thing as FDA approval of the medication itself. Registration means the facility is on file with and subject to FDA inspection under the Bioterrorism Act of 2002 and related FSMA requirements - it doesn't mean the FDA has evaluated or approved the specific compounded NAD+ preparation you'd receive. The medication remains not FDA-approved regardless of which type of facility prepares it. The materials reviewed for this article don't identify which of these six currently dispense NAD+ specifically - assignment is described generally as depending on the medication, the patient's shipping state, and current capacity.
Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed.
Learn more about the NAD+ program's structure - Pallas's clinical disclosures page covers this three-entity setup for every program on the platform.
The Fine-Print Gap: What the Terms of Service Say vs. What the NAD+ Program Actually Is
This is the kind of discrepancy worth surfacing directly rather than glossing over, because it's the sort of thing a careful reader would want flagged before enrolling.
What the Terms of Service say (Section 2, last updated July 11, 2026): "a telehealth platform connecting patients with US-licensed clinicians for evaluation and prescription of compounded GLP-1 medications (semaglutide and tirzepatide) when clinically appropriate." Section 12, covering pharmacy partners, is written the same way, and the clinical disclosures page's FDA-compounding section is scoped identically: "Pallas connects patients with clinicians who may prescribe compounded semaglutide and tirzepatide." NAD+ isn't named in any of the three.
What the live NAD+ pages show: an active, purchasable, clinician-prescribed NAD+ program with its own pricing, its own FAQ, and its own intake flow - clearly not a hypothetical or discontinued offering, and using the same "Plans, provider care included" pricing format and auto-renewal language as the GLP-1 line.
The reason for that gap isn't stated anywhere in the published materials - this article isn't going to guess at one. What matters for you as a buyer is confirming directly with support@pallashealth.co that the general Terms of Service - including its cancellation, refund, and billing terms - actually governs the NAD+ program, rather than assuming it by inference from the shared checkout design.
What Is NAD+? What the Research Actually Shows
Pallas states that NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell in the body. According to the brand's own product pages:
Found in every cell - central to converting nutrients into cellular energy
Involved in normal cellular repair processes
Levels tend to decline as the body ages
Available as a daily nasal spray or a weekly injection, your choice at intake
That's the brand's own framing, on its own product pages - not an independently verified scientific conclusion by this article.
What the brand adds - and this is worth taking at face value, since it works against the sales pitch, not for it - is a direct admission that the clinical picture is incomplete: "Research on supplemental NAD+ is still developing - which is why a US-licensed clinician reviews your health history and prescribes it only when it's appropriate for you." This article doesn't cite specific studies to support or dispute that statement; it's presented here as the brand's own characterization of where the evidence stands, not as an independently verified scientific conclusion.
Two distinctions matter here. First, general statements about NAD+ biology aren't the same as clinical trial data on Pallas Health's specific compounded preparation - no finished-product clinical trial data for this program was identified on the pages reviewed for this article. Second, "energy" and "healthy aging" as marketed benefits are positioned by the brand as goals members bring to the product, not as clinically validated outcomes the brand claims to guarantee. Individual experiences vary, and the brand's own materials say so.
It's also worth noting what Pallas's marketing doesn't claim. A lot of NAD+ therapy advertising elsewhere in this space reaches for cognitive function, metabolic health, and broad longevity claims. Pallas's own product pages, as reviewed for this article, stick to narrower language - energy metabolism and normal cellular processes - without extending into those additional claim categories. That's a difference worth noticing if you've been comparing NAD+ injection or NAD+ nasal spray programs across several telehealth brands: the claims themselves aren't uniform across the category, and narrower brand language isn't a weakness so much as a data point about how conservatively a given brand is willing to describe its own product.
Medical Leadership: Both Named Physicians Independently Confirmed
Pallas Health's clinical disclosures page names two members of what it calls "medical leadership," each with an NPI number and a note that licensure is verifiable through applicable state medical boards:
Dr. Ana Lisa Carr, MD - NPI 1689841744. Pallas states she's board-certified in family medicine, obesity medicine, and addiction medicine.
Dr. Kelly Tenbrink, MD - NPI 1346482684. Pallas states she's board-certified in emergency medicine.
The federal NPPES registry contains an NPI record corresponding to the number Pallas publishes for Dr. Ana Lisa Carr (1689841744), showing a Family Medicine taxonomy and provider-record details consistent with a Tennessee-based practice. It's worth being precise about what that confirms: NPPES itself notes that an NPI record documents registration, not current licensure or board-certification status - an NPI number doesn't, by itself, verify that a provider's license is active and unrestricted or that a specific board certification is current. So while a matching NPI record exists outside Pallas's own site, that alone doesn't independently verify the additional credentials Pallas's page attributes to her - "board-certified in family medicine, obesity medicine, and addiction medicine." Those certifications are brand-stated on Pallas's clinical disclosures page and weren't independently corroborated against a state medical board or certifying body for this article.
Dr. Kelly Tenbrink's listed NPI number (1346482684) independently corresponds to a real, actively practicing Emergency Medicine physician, corroborated across multiple third-party provider directories (including Healthline FindCare, US News Doctors, and Medical News Today), each independently listing the same board certification in Emergency Medicine that Pallas states. As with Dr. Carr, these directories confirm identity, licensure indication, and the specific certification claimed - they don't substitute for contacting the applicable state medical board directly if real-time license status matters to your decision.
Net of both checks: this article found no evidence that either named physician is fabricated or misrepresented. The one open item is narrower than the identity of either doctor - it's specifically the two additional specialties (obesity medicine and addiction medicine) Pallas attributes to Dr. Carr beyond her confirmed Family Medicine base, which weren't independently corroborated in the directories checked for this article.
Per the brand's materials, neither named individual is described as the specific clinician who will review any given patient's intake - Pallas states the full prescribing-clinician roster is maintained by Lion MD on the CareValidate platform and is available to any patient on request, with each patient given their specific treating clinician's name and license information before a prescription is issued.
How to Start: The 3-Step Enrollment Process
According to the official site, the process runs in three steps:
Complete the online intake. A roughly two-minute questionnaire covering health history, current medications, and goals. In states that permit asynchronous review, a licensed clinician can evaluate and prescribe from the intake alone.
Clinician review and, if appropriate, prescription. If the clinician determines treatment is appropriate, a prescription is issued and routed to a dispensing pharmacy. If not, the brand states the patient is not charged, or is refunded if a payment was already collected.
Ongoing care. The brand describes asynchronous messaging, dose-adjustment visits, and periodic follow-up evaluations. Refills are described as not automatic - each renewal reportedly involves clinician review of progress and tolerability before the next shipment goes out.
Medication is stated to ship free and discreet from a US-licensed pharmacy, often within about a week of approval, per the brand's materials.
Which States Require a Live Video Visit
Per the clinical disclosures page, Pallas Health states it accepts patients in all 50 US states and the District of Columbia. Most states permit an asynchronous review - meaning a clinician can evaluate the intake and prescribe without a live video call, requesting one only if clinically warranted. Seven states plus Washington, D.C. currently require a synchronous audio/video visit before the patient-provider relationship can be established:
Arkansas
Mississippi
New Mexico
North Dakota
Rhode Island
South Dakota
West Virginia
Washington, D.C.
If you're in one of those jurisdictions, expect the visit-deposit checkout flow described in the next section rather than a single upfront charge. Check your state directly on the enrollment page before starting the intake, since the checkout flow differs by jurisdiction.
Pallas Health NAD+ Pricing: Nasal Spray vs. Injection
Pricing below reflects the live product and treatment pages as fetched in August 2026. Pallas's Terms of Service state that subscription prices may change with at least 30 days' notice, effective at the start of the next billing cycle following that notice - so confirm current pricing at checkout rather than relying solely on the figures below.
Nasal spray: $79 for the first month, then $567 every 12 weeks - described by the brand as averaging $189/month.
Injection: $89 for the first month, then $597 every 12 weeks - described by the brand as averaging $199/month.
The brand states this is an all-in price covering the clinician review, ongoing check-ins, care-team messaging, and the medication itself when prescribed - with no separate membership fee layered on top. The part worth sitting with: per the Terms of Service, if your clinician doesn't prescribe, you get that money back in full. You're not paying to gamble on approval - you're paying for a clinician to actually look at your case, and the downside if it doesn't work out is bounded. The subscription auto-renews on that 12-week cadence unless canceled, and the site markets both options as FSA and HSA eligible, though eligibility for a specific plan ultimately depends on your own FSA/HSA administrator, not on Pallas's marketing claim alone.
A "pay over time" option is referenced as available at checkout but is not itself priced or described in detail on the pages reviewed - no interest rate, financing partner, or repayment term was disclosed in the materials checked for this article, so that detail should be confirmed directly at checkout rather than assumed.
Check the NAD+ program's current pricing page for your state before booking any required video visit.
The Visit Deposit and Charge-on-Approval Checkout, Explained
Pallas's general Terms of Service describe the following $60 deposit process for jurisdictions that require a live video visit (the seven states plus D.C. named above). Because those Terms currently name GLP-1 medications specifically rather than NAD+, confirm with Pallas that this same process governs the NAD+ program before relying on it as written below.
Checkout collects a $60 visit deposit and saves the payment method on file, instead of the full first-month payment.
That deposit is credited toward the first order.
If a clinician approves the plan after the video visit, Pallas is authorized to charge the remaining balance of the first payment to the saved method at the time of approval - and the recurring subscription begins from that approval date, not the original signup date.
If the clinician does not approve, or the patient cancels before a clinical decision is made, the Terms of Service state the $60 deposit is refunded in full.
If a patient doesn't attend or reschedule the required video visit and simply abandons the intake, the Terms of Service state the deposit "may be retained" rather than automatically refunded.
That last point is a real financial detail buried in Section 6 of the Terms - not something surfaced prominently on the marketing pages - and it's exactly the kind of clause worth reading, and confirming applies to NAD+, before booking a video visit you might not be able to make.
Pallas Health NAD+ Reviews and Complaints: What Can Be Verified
Pallas Health's site publishes five named testimonials under a "From our members" section, described as "quotes from Pallas members describing their care experience, shared with permission; names abbreviated for privacy." Reviewers are identified only by first name and last initial (for example, "Sarah M.," "David R."), each labeled "Verified member." No star rating, aggregate score, or review count accompanies these quotes, and no third-party review platform (Trustpilot, Google Reviews, BBB, etc.) is linked or cited on the pages reviewed. A footer disclosure on the site also notes that individuals shown in marketing may be actors or models, which is worth keeping in mind if any imagery accompanies the testimonials you see.
Two credibility badges appear on the site, worth naming and treating differently from each other:
"As seen in Forbes Health" - appears near the top of the homepage. The pages reviewed for this article don't link to or cite the specific placement, so this article treats it as a brand-displayed badge rather than a verified editorial feature, and can't confirm what form that coverage took.
"LegitScript Healthcare Merchant Certified" - unlike the Forbes badge, this one is independently checkable in seconds through LegitScript's own public verification tool. Worth doing before you enroll, not after.
Searches of Trustpilot and the Better Business Bureau conducted in August 2026 did not locate a dedicated review profile clearly attributable to pallashealth.co. That's a limited search, not a definitive finding - it doesn't establish that no independent consumer commentary exists anywhere, only that this article's review of those two platforms didn't surface one. What that does mean for you as a reader: the testimonials on Pallas's own site are brand-reported and not independently audited, with no outside audit trail confirming their volume, selection process, or representativeness. The accuracy of third-party review platforms generally is not endorsed by this article, and testimonials reflect individual service experiences, not guaranteed treatment outcomes, per the brand's own disclaimer accompanying the quotes.
Cancellation and Refund Policy, Line by Line
Pallas Health's Terms of Service, Section 7, lay out refund treatment in several distinct scenarios. As with the deposit mechanics above, these Terms are published as the platform's general policy and currently describe the underlying compounded-medication service in GLP-1-specific language - confirm with Pallas that they apply to NAD+ exactly as written before treating any of the following as guaranteed:
Clinician declines to prescribe, or an order isn't fulfilled and shipped: full refund, including any visit deposit collected under the charge-on-approval flow.
Patient cancels before a clinical decision is made: full refund of the deposit.
Patient cancels after paying, but before the pharmacy has been asked to fill the order: refund issued for the amount paid, minus third-party payment-processing costs and a $5 processing fee per refunded payment. The Terms of Service specify this deduction applies only to purchases made on or after July 14, 2026, and never applies to clinician-declined or unfulfilled orders.
Medication has already been dispensed and shipped: the order cannot be returned or refunded, except where required by applicable law.
Cancellation itself - separate from any refund - is described in the general Terms as always free and available anytime through account settings or by contacting Pallas directly, taking effect at the end of the current billing period rather than immediately. Again, confirm this applies to the NAD+ program specifically rather than assuming it from the shared checkout design.
Review current NAD+ plan pricing and refund terms directly on the enrollment page before you commit a payment method.
Pallas Health NAD+ Side Effects and Safety: What's Actually Disclosed
The NAD+ pages reviewed for this article don't publish a product-specific side-effect list. What the brand does disclose: your current medications, health conditions, and allergies are collected during the online intake, and the reviewing clinician uses that information to judge clinical appropriateness before prescribing. Individualized safety questions - including how NAD+ might interact with something you're already taking - are a matter for your assigned clinician, not something this article can answer generically.
Separately, Pallas's clinical disclosures page provides an adverse-event reporting path: patients are directed to report side effects both to their Pallas clinician and to FDA MedWatch at 1-800-FDA-1088 or fda.gov/safety/medwatch. That reporting mechanism is disclosed platform-wide rather than described specifically for NAD+, consistent with the broader documentation gap covered elsewhere in this article.
Factors to Consider Before Discussing Pallas Health NAD+ With a Clinician
Whether NAD+ is appropriate for any individual is a clinical decision, made by a licensed provider after reviewing your health history - not something this article, or any marketing page, can determine for you. The brand's own materials say the program "isn't right for everyone." What's useful here is naming the practical, non-clinical factors that shape whether this delivery model fits how you want to buy and manage a prescription:
You'd be getting a prescribed, pharmacist-compounded preparation rather than an over-the-counter capsule or powder - a different regulatory category with a different oversight process
The process runs fully online, through an intake questionnaire and clinician review, rather than an in-person visit (except in the states that require a synchronous video call)
Compounded medications aren't FDA-approved, so this isn't a route to an FDA-approved-drug product
Billing is a recurring 12-week charge averaging $189-$199/month after the discounted first month, not a one-time purchase
Exact dose and concentration are personalized after intake rather than published upfront, so you won't see fixed dosing information before you apply
The brand states this is private-pay only - no insurance accepted
If you're weighing this against an over-the-counter NAD+ or NAD+-precursor supplement instead, that's a structurally different product - sold without a prescription and without the clinical-review layer described throughout this article. The next section covers that distinction directly.
How Pallas Health Compares to Buying NAD+ Supplements Over the Counter
It's worth being direct about the category difference, since both are marketed under the "NAD+" name and a reader comparing options might conflate them. Dietary supplements marketed as NAD+ or NAD+-precursor products (capsules, powders, sublingual tablets) are sold without a prescription and without a clinician review step, and generally carry Supplement Facts labeling with disclosed dosing. By contrast, the Pallas NAD+ pages reviewed for this article do not publish a fixed dose or concentration before intake - dosing is described as personalized after clinician review.
Pallas Health's program sits in a different regulatory lane entirely: it's a prescription-only, pharmacist-compounded medication, gated by a clinician's clinical judgment rather than a retail purchase decision. This article doesn't attempt to compare the strength of clinical evidence between the two categories - that depends on the specific compound, dose, and delivery method involved, and evaluating it would require a defined product-by-product comparison this article doesn't undertake. What's clear structurally is that they're gated and priced differently, and a reader should choose based on which regulatory and clinical-oversight model they're actually looking for, not just which one showed up in an ad first.
OTC NAD+-related supplements vary substantially in formulation, dose, and price, so this article doesn't attempt a direct monthly cost comparison without a defined product set to compare against. What Pallas frames its higher price around is the clinical review and ongoing oversight layer bundled into the plan, not a claim that the compounded medication outperforms an OTC alternative at an equivalent dose.
Things to Verify Before You Enroll
None of the items below are accusations - they're documentation gaps or figures that weren't independently confirmable from the pages reviewed for this article, and the brand should be able to answer each one directly before you enter payment information.
Verify #1 - Does the general Terms of Service actually govern the NAD+ program? As documented above, the live Terms of Service and the FDA-compounding disclosure on the clinical disclosures page are both written to describe compounded GLP-1 medications by name and don't separately name NAD+. Confirm with support@pallashealth.co that the same subscription, cancellation, and refund terms apply.
Verify #2 - What specific dose and concentration will you receive? Neither the nasal spray nor the injection page discloses a fixed milligram dose or concentration; dosing is described as personalized after clinician review. Ask your assigned clinician directly before your first shipment ships.
Verify #3 - Which pharmacy actually dispenses NAD+? The brand names six platform-wide partner pharmacies but doesn't identify which of them currently handle NAD+ specifically, or which one will dispense a given order - that's described as depending on medication, shipping state, and current capacity. If you want to research a specific pharmacy's licensing and compounding history in advance, ask Pallas directly which pharmacy is likely to serve your state.
Verify #4 - What happens if you miss a required video-visit appointment? In the seven states plus D.C. that require a synchronous visit, the Terms of Service state the $60 deposit "may be retained" if you don't attend or reschedule and instead abandon the intake. Confirm the exact rescheduling window and grace period directly with support before booking.
Verify #5 - Dr. Ana Lisa Carr's licensure and additional board certifications. A matching NPI record with a Family Medicine taxonomy exists in the federal NPPES registry, but an NPI record doesn't itself verify current license status or board certification. Her stated certifications in obesity medicine and addiction medicine, as listed on Pallas's own page, weren't independently corroborated against a state medical board or certifying body for this article. If a specific credential matters to your decision, ask Lion MD directly for documentation, or check the applicable state medical board yourself.
Verify #6 - Independent review-platform data. No dedicated third-party review profile for pallashealth.co was located at the time of writing. If member feedback volume and rating history matter to your decision, ask the brand directly whether an aggregate rating exists on a platform not linked from their own site.
Verify #7 - How much of the site's own content is AI-generated. Pallas's footer includes a disclosure that "some content on this site is AI-generated; no representation or warranty is made regarding its accuracy, completeness, or reliability." That disclosure isn't scoped to a specific page or section, and every brand-stated fact in this article ultimately traces back to that same site. It doesn't make any individual claim false - but it's a real reason to independently confirm anything that would materially affect your decision, rather than treating the marketing pages as the final word.
Fast Facts: Pallas Health NAD+ at a Glance
Product type: Compounded prescription NAD+ (nasal spray or weekly injection) - not a dietary supplement
Platform/brand: Pallas Health - operating company: Brentmoor, Inc.
Licensed medical group: Lion MD, via the CareValidate clinical-operations platform
Dispensing pharmacies: Six named 503A/503B partners, assigned by state and capacity
First-month price, nasal spray: $79
First-month price, injection: $89
Ongoing average, nasal spray: $189/month ($567 every 12 weeks)
Ongoing average, injection: $199/month ($597 every 12 weeks)
Billing cycle: Recurring, every 12 weeks, auto-renews until canceled
Insurance: Not accepted - private pay only, per the brand
FSA/HSA eligibility: Brand-stated as eligible; confirm with your own plan administrator
States served: All 50 states plus Washington, D.C., per the brand
Video-visit-required states: Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia, plus D.C.
Shipping: Free, described as discreet, often within about one week of approval
Refund on clinician decline: Full refund, per the Terms of Service
Refund after payment, before pharmacy fill: Amount paid minus processing costs and a $5 fee (purchases on/after July 14, 2026)
Refund after shipment: Not eligible, except where required by law
Contact: hello@pallashealth.co · +1 (440) 601-3717 · Mon-Fri, 9 AM-5 PM ET
Find Pallas Health's NAD+ program information once you've confirmed the Fast Facts and Verify items above that matter most to you.
Quick Answer: Is Pallas Health's NAD+ Program FDA-Approved?
No. Pallas Health states that its NAD+ program involves a compounded medication, which is not FDA-approved and has not been evaluated by the FDA for safety, effectiveness, or quality. Pallas states that its compounded preparations are dispensed only after a treating clinician determines treatment is clinically appropriate, through its network of licensed 503A pharmacies and registered 503B outsourcing facilities.
Quick Answer: How Much Does Pallas Health's NAD+ Program Cost?
Per the brand's pricing page, the nasal spray starts at $79 for the first month, then bills $567 every 12 weeks (about $189/month). The injection starts at $89 for the first month, then bills $597 every 12 weeks (about $199/month). Both figures are brand-stated as all-in, covering clinician review, check-ins, messaging, and medication - confirm current pricing at checkout, since prices can change.
Quick Answer: What Happens If a Clinician Doesn't Approve My NAD+ Prescription?
Pallas Health's general Terms of Service state that if a licensed clinician reviews an intake and determines a compounded medication isn't clinically appropriate, the payment - including any visit deposit - is refunded in full, and nothing ships. That language, as published, is written around the GLP-1 line rather than NAD+ specifically, so confirm directly with Pallas that the same refund process applies to a declined NAD+ prescription.
Quick Answer: Can I Cancel My Pallas Health NAD+ Subscription Anytime?
Per Pallas's general Terms of Service, yes - cancellation is described as always free and available anytime through account settings or by contacting Pallas directly, though it takes effect at the end of the current billing period rather than immediately. Those Terms are written around the GLP-1 line rather than NAD+ specifically, so confirm they govern your NAD+ subscription before relying on this timeline. Whether a specific payment is refundable on top of cancellation depends on where in the billing and fulfillment cycle you cancel - see the refund breakdown earlier in this article.
Frequently Asked Questions
What is NAD+, in plain terms?
Pallas describes NAD+ (nicotinamide adenine dinucleotide) as a coenzyme found in every cell of the body, involved in converting nutrients into cellular energy and in normal cellular repair processes, with levels that decline with age. Those are the brand's own statements, presented here as its scientific framing rather than as independently established conclusions of this article. Whether replenishing NAD+ through a prescribed nasal spray or injection produces measurable benefits in energy or aging outcomes is, per the brand's own product page, an area of ongoing, still-developing research.
Is Pallas Health's NAD+ program a dietary supplement?
No. It's marketed and dispensed as a compounded prescription medication, not a dietary supplement. That means there's no Supplement Facts panel to review, and access requires a clinician's prescription rather than a simple retail purchase. This is a meaningfully different regulatory category than an over-the-counter NAD+ capsule or powder.
Who actually prescribes the medication?
A US-licensed clinician affiliated with Lion MD, the clinical partner network named on Pallas Health's clinical disclosures page, reviews each patient's intake and makes an independent prescribing decision. Pallas Health itself, as the technology platform, does not employ providers or make clinical decisions, per its own disclosures.
Do I need a video call to get prescribed?
Only if you're located in one of the states that require it: Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia, or Washington, D.C. In other states, the brand states a clinician can evaluate and prescribe based on the written intake alone, requesting a video visit only when clinically warranted.
How much does the nasal spray cost compared to the injection?
The nasal spray starts at $79 for the first month, then $567 every 12 weeks (about $189/month). The injection starts at $89 for the first month, then $597 every 12 weeks (about $199/month). Both are billed on a recurring basis and auto-renew until canceled, per the brand's pricing page.
Is the price guaranteed not to increase?
The product page states "one price - never increases," while the Terms of Service separately reserve the right to change subscription prices with at least 30 days' notice, effective at the start of the next billing cycle following that notice. The published materials don't explain how these two statements are meant to be reconciled. If long-term price stability matters to your decision, confirm current price-protection terms directly with Pallas.
Does insurance cover this program?
No. Pallas Health states plainly across its footer disclosures that this is "private pay only (no insurance)." The site separately markets the plans as FSA and HSA eligible, but eligibility for a specific expense ultimately depends on your own plan administrator's rules, not on the brand's marketing claim alone.
Confirm current NAD+ pricing and eligibility directly with Pallas if any of the answers above raise a question specific to your state.
What pharmacy fills my prescription?
Pallas Health's clinical disclosures page lists six platform-wide partner pharmacies - Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, and Foothills Pharmacy. The materials reviewed don't say which of those six currently dispense NAD+ specifically; assignment for any order is described as depending on the medication, your shipping state, and current capacity, and isn't disclosed until assigned.
Can I get a refund after my medication ships?
Generally, no. Per the Terms of Service, once medication has been dispensed and shipped, the order cannot be returned or refunded, except where required by applicable law. Refunds are available at earlier stages - before a clinical decision, on clinician decline, or before the pharmacy has been asked to fill the order - each with different terms detailed in this article's refund section.
How long does shipping take?
The brand states medication ships free and discreet from a US-licensed pharmacy, often within about a week of a clinician's approval. No guaranteed delivery window beyond "often within a week" was published on the pages reviewed for this article.
Is Pallas Health's NAD+ program the same as buying NAD+ supplements online?
No, and this distinction matters. Over-the-counter NAD+ or NAD+-precursor supplements are sold without a prescription and carry a Supplement Facts panel with disclosed dosing. Pallas Health's program is a prescription-only compounded medication gated by a clinician's independent clinical judgment, with dosing personalized after intake rather than fixed and published upfront.
What if I don't attend my required video visit?
In the states that require a synchronous video visit, checkout collects a $60 deposit rather than a full first payment. Per the Terms of Service, if you don't attend or reschedule that visit and instead abandon your intake, the deposit "may be retained" rather than automatically refunded - a detail worth confirming directly with support before booking.
Are the testimonials on Pallas Health's site independently verified?
The five testimonials published on the site are labeled "Verified member" by the brand and described as shared with permission, with names abbreviated for privacy. No third-party review platform, star rating, or aggregate review count accompanies them. A search of Trustpilot and BBB in August 2026 didn't locate a dedicated profile for the company, though that's a limited search, not proof none exists. The accuracy of third-party review platforms generally is not endorsed by this article.
Does the NAD+ program treat any specific medical condition?
No specific diagnosed condition is named as a treatment target on the pages reviewed. The brand positions the program around two self-selected goals - everyday energy and healthy aging - and states directly that a clinician determines appropriateness on a case-by-case basis, adding that the program "isn't right for everyone."
Who do I contact with questions about my order or the company itself?
General questions go to hello@pallashealth.co or +1 (440) 601-3717 (Mon-Fri, 9 AM-5 PM ET). Compliance-related questions, including requests to verify a specific clinician's licensure, are directed to support@pallashealth.co per the clinical disclosures page.
Is Pallas Health's NAD+ program legit?
Rather than offer a verdict, here's what's independently checkable: the operating entity (Brentmoor, Inc.), the licensed medical group (Lion MD), and six named partner pharmacies are all disclosed on the brand's own clinical disclosures page. Both named clinicians independently check out as real, actively practicing physicians against the federal registry and other public provider directories. Pallas also states it's LegitScript Healthcare Merchant Certified, which you can verify directly through LegitScript's own checker. Two things remain unresolved: the Terms of Service gap covered above, and the absence of independent third-party review data. Weigh all of it together rather than any single signal.
Does NAD+ therapy actually work?
That depends on what "work" means to you, and this article isn't positioned to settle it. NAD+'s basic role in cellular energy metabolism is well established biology; whether replenishing it through a prescribed nasal spray or injection produces noticeable results for a given person is, per Pallas's own product page, still-developing research territory. The brand doesn't promise a specific outcome, and neither does this article.
Can Pallas Health prescribe NAD+ if I'm already taking other medications?
The brand states the intake questionnaire collects current medications, health conditions, and allergies, which the reviewing clinician uses to determine clinical appropriateness. No specific drug-interaction list for NAD+ was published on the pages reviewed for this article; that assessment is described as an individualized clinical judgment made by your assigned provider rather than a fixed rule disclosed up front, so it's worth raising any current prescriptions directly during intake.
How does Pallas Health handle my health information?
Per Pallas's Privacy Policy, health information you submit is treated as Protected Health Information under HIPAA, with Pallas Health acting as a Business Associate to a contracted clinical partner organization that serves as the HIPAA Covered Entity for medical records. The policy also discloses that certain in-app features - including an AI chat assistant and voice-note transcription - send de-identified content to third-party AI providers to generate responses, under terms that the policy states prevent that data from being used for model training. This level of detail is unusual for a telehealth landing page to spell out, and it's worth reading the full Privacy Policy yourself if data handling factors into your decision.
Buyer Verification Checklist
Confirm your state is on the list requiring a live video visit, or confirm asynchronous review applies to you
Ask support@pallashealth.co directly whether the general Terms of Service govern the NAD+ program specifically
Confirm current pricing for your preferred delivery method (nasal spray or injection) at checkout, since figures can change
Ask your assigned clinician for the specific dose and concentration you'll be prescribed before your first shipment
If your state requires a video visit, confirm the rescheduling window for that appointment before you book it
Confirm your FSA/HSA administrator will actually reimburse this specific expense before assuming eligibility
Save or screenshot the refund policy at the time you enroll, since it references a July 14, 2026 effective date for fee deductions
Ask which of the six partner pharmacies is likely to serve your shipping state, if pharmacy-specific research matters to you
See current Pallas Health NAD+ program information
The Bottom Line
Pallas Health's NAD+ program works like this: a US-licensed clinician reviews an online intake, decides whether prescribing NAD+ is appropriate, and - if so - a partner pharmacy compounds and ships either a daily nasal spray or a weekly injection on a recurring 12-week billing cycle. The published materials describe pricing, recurring billing, clinician review, refund terms at each stage, and the platform-level pharmacy relationships in specific, checkable detail. Both named medical leaders independently check out as real, actively practicing physicians against the federal registry and other public directories; the one open item is narrower - two additional specialty certifications attributed to one physician beyond her confirmed base credential.
Two documentation gaps are worth carrying into your own decision, because this article documented them directly rather than assuming past them:
The published Terms of Service describe the platform's compounded-medication service using GLP-1-specific language and don't separately name NAD+.
The limited third-party review search described above didn't locate a dedicated Pallas Health profile.
Neither one is resolved by this article - both are exactly the kind of detail worth a two-minute email to support@pallashealth.co before you enter a payment method, especially given the auto-renewing, 12-week billing structure. Beyond those two open items, verify any material term that matters to your decision directly with Pallas before enrolling.
Here's the practical takeaway: two documentation gaps are genuinely worth a two-minute email before you pay anything - but they're the kind of gaps you close with a question, not reasons to walk away on their own. If clinician-reviewed access to NAD+, a bounded refund if you're declined, and your choice of nasal spray or injection line up with what you came here looking for, the next step costs you nothing but two minutes.
If you came here comparing Pallas Health's programs generally rather than NAD+ specifically, the platform's compounded-vs-brand-name GLP-1 pricing breakdown covers the weight-management side of the same three-entity structure, with its own pricing table and refund documentation specific to that program.
Pallas Health Contact Information
Operating entity: Pallas Health (operated by Brentmoor, Inc.)
Mailing address: 131 Continental Dr, Suite 305, Newark, DE 19713
General inquiries: hello@pallashealth.co
Compliance / licensure verification: support@pallashealth.co
Phone: +1 (440) 601-3717 (Mon-Fri, 9 AM-5 PM ET)
Official site: pallashealth.co
See Pallas Health's current NAD+ pricing and program details
Disclosure and Compliance Information
Material Limitations. This article is based on the official Pallas Health website, the NAD+ product and treatment pages, the Terms of Service, the Privacy Policy, and the Clinical Disclosures page, all fetched directly in August 2026, plus independent verification of both named clinicians' NPI records against the federal registry and other public provider directories. No independent product testing was performed, and brand claims - including pricing, refund mechanics, testimonial content, and credibility badges - are not independently verified beyond what's noted directly in this article. Pallas's own site discloses that some of its content is AI-generated, without a stated accuracy or completeness warranty; this article treats that as a reason for added reader caution rather than as grounds to discount any specific claim. Facts that could not be confirmed from the sources reviewed, including the specific dose/concentration of either delivery method, the pay-over-time financing terms, the Forbes Health placement referenced on the homepage, and Dr. Ana Lisa Carr's obesity-medicine and addiction-medicine board certifications, were not asserted as fact and are flagged in the Things to Verify section above. Where this article notes a discrepancy between the brand's Terms of Service and its live NAD+ product pages, that discrepancy is documented as observed, without asserting a cause. Readers should contact the brand directly to verify any material claim before purchasing.
Third-Party Consumer Feedback Platforms. The accuracy of third-party review platforms is not endorsed. No independent Trustpilot, BBB, or comparable third-party review profile specific to Pallas Health's NAD+ program was located as of the research date for this article; the testimonials referenced in this article are sourced solely from the brand's own website and should be evaluated critically alongside that limitation.
Forward-Looking Statements. This article reflects information gathered in August 2026. Specifications, refund policies, state availability, and clinical partnerships are subject to change. Pallas's Terms of Service state that subscription prices may change with at least 30 days' notice, effective at the start of the next billing cycle following that notice. Readers should rely on Pallas Health's official site and direct communication with the company for current information before making a purchasing decision.
Marketing Language Notice. Attribution language throughout this article (phrases such as "the brand states," "per the brand's materials," and similar) identifies claims originating from Pallas Health's own marketing and legal pages. These are brand-asserted marketing and policy language, not independent rankings, lab-verified claims, or endorsements by this publication.
Compounded Medication Disclosure. Pallas Health states that its compounded preparations, including the NAD+ preparations discussed in this article, are not FDA-approved and that prescriptions are issued only when a treating clinician determines treatment is clinically appropriate. Pallas lists licensed 503A compounding pharmacies and registered 503B outsourcing facilities among its platform pharmacy partners.
Prescribing Separation Language. Prescription medication discussed in this article is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed, and this article does not represent or imply that any specific reader will be approved for treatment.
California Proposition 65. No Proposition 65 warning specific to this compounded NAD+ preparation was identified in the materials reviewed for this article. This product is a prescription pharmaceutical dispensed through a licensed compounding pharmacy rather than sold as a standard retail consumer good, and this article does not assert that a Proposition 65 warning does or doesn't apply. California readers with questions should confirm directly with Pallas Health or the assigned dispensing pharmacy.
Geographic / Jurisdictional Notice. Availability, prescribing rules, and required visit types vary by state, as detailed in this article. Readers outside the United States should not assume this program is available to them; the brand states service is limited to the 50 US states and the District of Columbia.
Warranty Notice. No express or implied warranty regarding treatment outcomes, product efficacy, or approval likelihood is made by this article. Per the brand's own Terms of Service, the platform is provided "as is," and specific treatment outcomes are not guaranteed.
Insurance and HSA/FSA Notice. This article does not confirm insurance coverage or HSA/FSA reimbursement for any individual reader. The brand markets the program as private-pay only and states plans are FSA/HSA eligible; reimbursement ultimately depends on the buyer's specific plan and is not confirmed by this article.
Auto-Renewal / Subscription Disclosure. The NAD+ program bills on a recurring 12-week cycle and auto-renews until canceled. Cancellation method, deadline, and billing-cycle mechanics, as disclosed by Pallas Health's own Terms of Service, are covered in the Cancellation and Refund Policy section of this article. No subscription mechanic beyond what is documented directly in this article and sourced from the brand's own Terms of Service is confirmed or implied.
Trademark Acknowledgment. Pallas Health, Lion MD, CareValidate, Brentmoor, Inc., and all named partner pharmacies are trademarks or trade names of their respective owners. No trademark registration (®) claim is made on behalf of any name in this article absent explicit confirmation on the brand's own pages; none was identified for the specific "Pallas Health" or "NAD+ Program" naming on the pages reviewed.
Publisher Responsibility Limitation. Content claims in this article are attributed to Pallas Health and are not independently endorsed. A commission may be earned if a purchase is made through links in this article. This article was prepared for consumer education regarding a commercially available program and is promotional in nature.
SOURCE: Pallas Health
View the original press release on ACCESS Newswire